Cart
sales@molnova.com
Lucidenic acid SP1 (Lucidenic acid LM1)
CAS No. 364622-33-3
Lucidenic acid SP1 (Lucidenic acid LM1)( —— )
Catalog No. M31665 CAS No. 364622-33-3
Lucidenic acid SP1 is a natural product.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 396 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLucidenic acid SP1 (Lucidenic acid LM1)
-
NoteResearch use only, not for human use.
-
Brief DescriptionLucidenic acid SP1 is a natural product.
-
DescriptionLucidenic acid SP1 is a natural product.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number364622-33-3
-
Formula Weight460.6
-
Molecular FormulaC27H40O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Pivagabine
Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.
-
2-Iodobenzoic acid
2-Iodobenzoic acid is the impact-sensitive intermediate in the synthesis of the Dess-Martin periodinane.
-
Lumiliximab
Lumiliximab (IDEC-152) is a primate-ized chimeric antibody targeting CD23 rhesus monkey/human chimeric antibody with inhibitory effects on IgE antibody production for the study of allergic diseases.
